RecruitingNCT04212455
A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)
Sponsor
Guangdong Provincial People's Hospital
Enrollment
50,000 participants
Start Date
Jan 1, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- ≥18 years old
- In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)
Exclusion Criteria3
- \<18 years old
- Unsigned informed consent
- Pregnant Women and Lactation
Interventions
OTHERNon-interventional study
This is an observational, non-interventional study
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04212455
Related Trials
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NCT074614154 locations
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
NCT074820201 location